News

BB-meta-HF: Efficacy of beta-blockers in heart failure patients with atrial fibrillation: Individual patient meta-analysis from the Beta-blockers in Heart Failure Collaborative Group

03.09.20141774

Atrial fibrillation (AF) and heart failure (HF) frequently coexist, causing substantial cardiovascular (CV) morbidity and mortality.

The British Heart Foundation Fractional Flow Reserve versus Angiography in Guiding Management to Optimise Outcomes in Non-ST-Segment Elevation Myocardial Infarction

02.09.20141871

We assessed the management and outcomes of non-ST segment elevation myocardial infarction (NSTEMI) patients randomly assigned to fractional flow reserve (FFR)-guided management or angiography-guided standard care.

Is There a Difference in STEMI Response Between Women and Men Undergoing PCI?

01.09.20141637

In age-matched women and men with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) with everolimus-eluting stents (ESS).

Does physical activity modify the relationship between obesity and atrial fibrillation (AF) in women?

29.08.20141494

Does physical activity modify the relationship between obesity and atrial fibrillation (AF) in women?

Electrocardiographic Changes Improve Risk Prediction in Asymptomatic Persons Age 65 Years or Above Without Cardiovascular Disease

28.08.20141677

Risk prediction in elderly patients is increasingly relevant due to longer life expectancy.

Hypertension self-management program linked to lower BP at 12 months

27.08.20141664

For the TASMIN-SR trial, Richard J. McManus, FRCGP, and colleagues studied 552 patients aged 35 years and older with baseline systolic BP ?130 mm Hg/diastolic BP ?80 mm Hg who had a history of stroke, CHD, diabetes or chronic kidney disease.

Aspirin reduced risk for recurrent VTE

26.08.20141759

После венозной тромбоэмболии ((ВТЭ) тромбоза глубоких вен или легочной эмболии) большинство пациентов принимают варфарин или новые пероральные антикоагулянты в течение 6 - 12 месяцев, после окончания терапии у таких пациентов остается риск рецидива ВТЭ.